Company Profile

Structured around development of assistive technologies to measure, monitor, and treat individuals with Alzheimer’s disease MapHabit is using software in lieu of or in combination with medication. The firm is developing mobile device software giving users a chance to perform and experience activities previously lost to Alzheimer’s disease and related dementias. Breaking down complex tasks into fully customizable incremental steps, MapHabit aims to restore function by guiding users and capturing details about how they live their daily lives. Measuring disease trajectory so they can make informed care decisions, MapHabit helps those with memory impairment to regain independence to enhance their quality of life and facilitates consistency of care. Using task-mapping – based on a memory technique called mind-mapping used in scientific research, business planning, and education to improve recall by organizing key bits into a memory bank powered by pictures, words, and quotes – the system walks users through manageable steps that are the components of an essential activity of daily life. Reflecting a rising trend as nation ages, six million people in the US alone are living with Alzheimer’s and one in three will die with it. It is among the costliest segment of the US healthcare system -- currently $210 billion annually and predicted to reach $1.1 trillion by 2050